Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients

Rev. Soc. Bras. Med. Trop; 52 (), 2019
Publication year: 2019

Abstract INTRODUCTION:

Concern regarding the cardiotoxicity of antimalarials has been renewed because of their potential to cause QT/QTc interval prolongation related to torsade de pointes (TdP). Artemisinin-piperaquine (AP) is considered an effective artemisinin-based combination therapy (ACT) for malaria.

METHODS:

This study involved a retrospective analysis of clinical data of 93 hospitalized malaria patients who had received AP orally. Electrocardiograms (ECGs) were obtained at specific time points in the original study.

RESULTS:

Some cases of QT prolongation were observed. However, no TdP was found.

CONCLUSIONS:

AP may cause QT interval prolongation in some malaria patients but may not lead to TdP.

More related

No related documents